1. Home
  2. BLLN vs VIRT Comparison

BLLN vs VIRT Comparison

Compare BLLN & VIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

HOLD

Current Price

$128.58

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo Virtu Financial Inc.

VIRT

Virtu Financial Inc.

HOLD

Current Price

$56.96

Market Cap

4.8B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLLN
VIRT
Founded
2016
2008
Country
United States
United States
Employees
713
N/A
Industry
Medical Specialities
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
4.8B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
BLLN
VIRT
Price
$128.58
$56.96
Analyst Decision
Buy
Hold
Analyst Count
7
5
Target Price
$126.71
$45.60
AVG Volume (30 Days)
706.5K
1.3M
Earning Date
05-06-2026
04-29-2026
Dividend Yield
N/A
1.89%
EPS Growth
N/A
72.73
EPS
N/A
1.99
Revenue
N/A
$3,632,118,000.00
Revenue This Year
$46.29
N/A
Revenue Next Year
$30.14
$1.34
P/E Ratio
N/A
$28.47
Revenue Growth
N/A
26.25
52 Week Low
$61.96
$31.55
52 Week High
$138.70
$68.02

Technical Indicators

Market Signals
Indicator
BLLN
VIRT
Relative Strength Index (RSI) 63.97 44.91
Support Level $79.07 $56.81
Resistance Level $138.70 $64.88
Average True Range (ATR) 6.93 2.29
MACD -0.21 -1.14
Stochastic Oscillator 91.96 15.26

Price Performance

Historical Comparison
BLLN
VIRT

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

About VIRT Virtu Financial Inc.

Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.

Share on Social Networks: